title: [Autism, epilepsy and tuberous sclerosis complex: a functional model linked to mTOR pathway].
abstract: BACKGROUND
  Tuberous sclerosis complex (TSC) is an autosomal dominant disorder that results from mutations in the TSC1 or TSC2 genes and is associated with hamartoma formation in multiple organ systems. Brain disorders are the origin of more frequent and severe problems and include infantile spasms, intractable epilepsy, brain tumors, cognitive disabilities, and autism. TSC1 or TSC2 encoded proteins modulate cell function via the mTOR signaling cascade and serve as keystones in regulating cell growth and proliferation. AIM. To review the etiopathogenic mechanisms and the natural course of the association of autism and epilepsy in TSC.
  
  
  METHODS
  Both the clinical and the neuroimaging findings of TSC, including early onset epilepsy and the localization of cortical tubers in the temporal lobes, and the molecular understanding of the mTOR signaling pathway, not only involved in cell growth, but also in synaptogenesis, synaptic plasticity and neuronal functioning, have suggested a multimodal origin of autism in these patients.
  
  
  CONCLUSIONS
  A greater understanding of the pathogenetic mechanisms underlying autism in TSC could help in devising targeted and potentially more effective treatment strategies. Antagonism of the mTOR pathway with rapamycin and everolimus may provide new therapeutic options for these TSC patients.
authors: Hospital Infantil Universitario Nino Jesus, Avda. Menéndez Pelayo 65, Madrid, Spain. jgarciape.hnjs@gmail.com
authors: Juan José
authors: JJ
authors: García-Peñas
authors: Inmaculada
authors: I
authors: Carreras-Sááez
mesh_terms: D001321:Autistic Disorder / Q000150:complications / Q000188:drug therapy / Q000209:etiology*; D002648:Child; D004827:Epilepsy / Q000150:complications / Q000188:drug therapy / Q000209:etiology*; D006801:Humans; D008954:Models, Biological; D015398:Signal Transduction; D058570:TOR Serine-Threonine Kinases / Q000502:physiology*; D014402:Tuberous Sclerosis / Q000150:complications* / Q000188:drug therapy / Q000209:etiology
chemical_list: C546842:MTOR protein, human; D058570:TOR Serine-Threonine Kinases